Results 171 to 180 of about 595,493 (289)

Research Progress of Annexin A1 and Its Derived Peptides in the Diagnosis and Treatment of Circulatory Diseases

open access: yesImmunity, Inflammation and Disease, Volume 13, Issue 11, November 2025.
ABSTRACT Background Annexin A1 (ANXA1), a calcium‐dependent phospholipid‐binding protein, plays a critical role in regulating inflammation, apoptosis, immune responses, and vascular remodeling. It is increasingly recognized for its potential as a therapeutic target and diagnostic biomarker in various circulatory diseases, including sepsis, hypertension,
Qiuyu Dai   +4 more
wiley   +1 more source

Preinfarction angina protects against in-hospital adverse outcomes in the elderly

open access: yesCurrent Controlled Trials in Cardiovascular Medicine, 2001
Lyford Joanna   +11 more
doaj   +1 more source

Neoadjuvant Chemoimmunotherapy Combined With Node‐Sparing Radiotherapy for Clinical T3N+ Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Single‐Arm, Phase II Study (CINSREC Trial)

open access: yesThoracic Cancer, Volume 16, Issue 22, November 2025.
The CINSREC trial is the first prospective clinical trial to investigate the safety and efficacy of NCIT combined with node‐sparing radiotherapy for clinical T3N+ locally advanced ESCC. This strategy may provide a better pCR rate and acceptable safety. ABSTRACT Introduction The promising therapeutic outcomes of neoadjuvant chemoimmunotherapy (NCIT) in ...
Xu Zhou   +8 more
wiley   +1 more source

Selatogrel: Potential to redefine timely anti‐platelet intervention

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 22, Page 5435-5452, November 2025.
Acute coronary syndrome (ACS) encompasses a number of heart diseases that cause a sudden decrease in coronary perfusion, precipitating cardiomyocyte necrosis or heightened risk thereof. This pathology is a major burden of cardiovascular disease.
Rudy N. Zalzal   +3 more
wiley   +1 more source

Unstable Angina: Is It Time for a Requiem?

open access: yesCirculation, 2013
E. Braunwald, D. Morrow
semanticscholar   +1 more source

Long‐term efficacy and safety of tirzepatide in participants with type 2 diabetes with inadequate glycaemic control on metformin and/or sulfonylurea: Post‐hoc analysis of SURPASS‐4

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 11, Page 6480-6490, November 2025.
Abstract Aim To evaluate the long‐term efficacy and safety data at 104 weeks in tirzepatide‐treated participants with type 2 diabetes who had inadequate glycaemic control on metformin and/or sulfonylurea. Materials and Methods This post‐hoc analysis was based on the SURPASS‐4 data (NCT03730662), a multicenter, Phase III trial.
Haixia Guan   +5 more
wiley   +1 more source

ASSESSMENT OF INTERVENTION TREATMENT OF UNSTABLE ANGINA OF PATIENTS OF DIABETES MELLITUS TYPE 2

open access: hybrid, 2008
Ch. F. Leshkevich   +5 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy